{"id":424035,"date":"2022-10-14T08:23:48","date_gmt":"2022-10-14T08:23:48","guid":{"rendered":"https:\/\/teknomers.com\/es\/la-familia-colruyt-invierte-en-un-nuevo-tratamiento-contra-el-cancer\/"},"modified":"2022-10-14T08:23:49","modified_gmt":"2022-10-14T08:23:49","slug":"la-familia-colruyt-invierte-en-un-nuevo-tratamiento-contra-el-cancer","status":"publish","type":"post","link":"https:\/\/teknomers.com\/es\/la-familia-colruyt-invierte-en-un-nuevo-tratamiento-contra-el-cancer\/","title":{"rendered":"La familia Colruyt invierte en un nuevo tratamiento contra el c\u00e1ncer"},"content":{"rendered":"\n<div>\n<p class=\"article__paragraph\">La inversi\u00f3n se realiza a trav\u00e9s de Korys, la sociedad inversora de Colruyts.  A trav\u00e9s del fondo de inversi\u00f3n OMX Europe Venture Fund, la familia Colruyt invierte en atenci\u00f3n sanitaria innovadora junto con la sociedad de inversi\u00f3n francesa M\u00e9rieux Equity Partners.<\/p>\n<\/div>\n<div>\n<p class=\"article__paragraph\">Ahora ese fondo est\u00e1 entrando en la empresa francesa de biotecnolog\u00eda Mablink.  Esto ha levantado 31 millones de euros en capital nuevo.  Ese dinero debe usarse para traer un nuevo tratamiento contra el c\u00e1ncer al mercado.  Mablink est\u00e1 trabajando espec\u00edficamente en una nueva generaci\u00f3n de medicamentos contra el c\u00e1ncer para pacientes que no pueden ser tratados en la actualidad.<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.hln.be\/geld\/familie-colruyt-investeert-in-nieuwe-kankerbehandeling~ad1ad282\/\" rel=\"nofollow noopener\" target=\"_blank\">ttn-es-34<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La inversi\u00f3n se realiza a trav\u00e9s de Korys, la sociedad inversora de Colruyts. A trav\u00e9s del fondo de<\/p>\n","protected":false},"author":1,"featured_media":424036,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[6131,15607,110,126,5888,480,2628],"class_list":["post-424035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-cancer","tag-colruyt","tag-contra","tag-familia","tag-invierte","tag-nuevo","tag-tratamiento"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/424035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/comments?post=424035"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/424035\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media\/424036"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media?parent=424035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/categories?post=424035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/tags?post=424035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}